Melissa Kotterman

Colleagues at Berkeley Frontier

AS

Alberto Sangiovanni-Vincentelli

Co-founder, Cadence; Synopsys; Chair of Berkeley EECS at Berkeley Frontier

AC

Alfred Chu

Founder, Starlite Investment Group at Berkeley Frontier

AC

Alfred Chu

Managing Partner, Starlite Investment Group at iFly.vc

AT

Alvin Tang

Assistant Physician-in-Chief, The Permanente Medical Group at Berkeley Frontier

BC

Ben Chan

Venture Partner at Berkeley Frontier

CW

Caroline Winnett

Angel at Berkeley Skydeck Fund

CH

Charles Huang

Co-founder of Guitar Hero, Berkeley Foundation Trustee at Berkeley Frontier

CR

Chethan Ramachandran

Venture Partner at Berkeley Frontier

Frequently asked questions

Who is Melissa Kotterman?

Melissa Kotterman is Chief Executive Officer at Vivere Oncotherapies and serves as a board member. Her research background is in biopharmaceuticals, focusing on early-stage discovery and preclinical studies, with expertise in viral gene therapy and the use of adeno-associated virus (AAV) for rare and complex diseases. She has developed viral gene delivery vectors targeting more than 10 tissue and cell types, including human embryonic stem cells and adult neural stem cells, with additional research interests in infectious disease, regenerative medicine, neuroscience, and oncology.

Where does Melissa Kotterman work?

Melissa Kotterman is Venture Partner at Berkeley Frontier.

Where did Melissa Kotterman go to school?

Melissa Kotterman studied at University of California, Berkeley (Doctor of Philosophy (Ph.D.), Chemical and Biomolecular Engineering); Carnegie Mellon University (Bachelor of Science (B.S.), Chemical Engineering).